Uniplan Investment Counsel’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.3K Buy
+451
New +$43K 0.01% 154
2020
Q4
Sell
-82,137
Closed -$2.67M 127
2020
Q3
$2.67M Buy
82,137
+588
+0.7% +$17.7K 0.19% 82
2020
Q2
$2.15M Buy
81,549
+340
+0.4% +$8.89K 0.15% 88
2020
Q1
$2.02M Buy
+81,209
New +$2.51M 0.15% 80
2015
Q4
Sell
-345,934
Closed -$4.22M 113
2015
Q3
$4.22M Sell
345,934
-127,991
-27% -$1.64M 0.2% 88
2015
Q2
$5.71M Buy
+473,925
New +$4.67M 0.26% 77

Other funds holding LMAT

Uniplan Investment Counsel's LMAT Position: Q1 2026 in Review

Uniplan Investment Counsel opened a new position in LeMaitre Vascular (LMAT) in Q1 2026: 451 shares worth $49.3K. The stake represents 0.01% of the portfolio and ranks #154 among its holdings. This is a return to the name: Uniplan Investment Counsel previously reported a position in LMAT as recently as Q3 2020.

Uniplan Investment Counsel first reported a position in LMAT in Q2 2015 and has held it in 6 quarters since. The position peaked at $5.71M in Q2 2015. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Uniplan Investment Counsel held 451 shares of LeMaitre Vascular worth $49.3K as of Q1 2026.
  • LeMaitre Vascular was a new Uniplan Investment Counsel position in Q1 2026.
  • LeMaitre Vascular made up 0.01% of Uniplan Investment Counsel's portfolio in Q1 2026, its #154 holding.
  • Uniplan Investment Counsel first reported a position in LeMaitre Vascular in Q2 2015 and has held it in 6 quarters since.
  • Uniplan Investment Counsel's LeMaitre Vascular position peaked at $5.71M in Q2 2015.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Uniplan Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.